Author Archives: biocon
Learning/teaching/training activities of our students based on the project: ΚΑ2 Erasmus+1 ΚΑ2 Erasmus+1″Biosafety in Biotechnology: Connecting Academia with the Bioeconomy Market”
Rheumatoid Arthritis (RA) is an autoimmune and inflammatory disease that affects the synovium (lining that surrounds the joints), causing the immune system to attack its own healthy tissues. Treatment options, to the current day, have serious limitations and merely offer short-term alleviation to the pain. Using a theoretical exercise based on literature, a new potentially […]
With the spectre of climate change looming and a population predicted to reach almost 10 billion by 2050, developing a sustainable food system to cope with these challenges is imperative.
In the 1930s, neurosurgeon Wilder Penfield pioneered a daring new kind of cartography. As a stenographer took notes, he delicately touched an electrode to the exposed brains of his awake, consenting patients and asked what they felt as electrical current hit different areas.
A strategy for fighting dengue fever with bacteria-armed mosquitoes has passed its most rigorous test yet: a large, randomized, controlled trial.
Faced with short supplies of COVID-19 vaccines and unforeseen side effects, some countries have adopted an unproven strategy: switching shots midstream.
By rewriting the genome of Escherichia coli, researchers incorporated several unnatural amino acids into bacterial proteins.
The COVID-19 vaccine made by Pfizer and BioNTech appears to put young men at elevated risk of developing a heart muscle inflammation called myocarditis, researchers in Israel say.
Researchers are searching for possible links between unusual clotting and the Oxford–AstraZeneca coronavirus vaccine.